Philips Announces Changes to its Executive Committee

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has announced the appointment of Jeroen Tas as Chief Innovation & Strategy Officer to accelerate Philips' transition to a solutions company, driving innovations in systems, smart devices, software and services to improve people's lives. Effective immediately, Jeroen Tas is responsible for strategy, research & development, design, medical affairs, sustainability, platforms, emerging businesses and process excellence to bring innovations to market. In his new role, Jeroen Tas replaces Jean Botti, who has left the company.

At the same time, Philips has appointed Carla Kriwet as Chief Business Leader of the Connected Care & Health Informatics businesses and new member of the Executive Committee. In this role, she succeeds Jeroen Tas with immediate effect. In addition, she will continue to lead the Business Group Patient Care & Monitoring Solutions, which is part of the Connected Care & Health Informatics segment.

As a further change to Philips' Executive Committee, Ronald de Jong has been appointed as Global Head of Human Resources (HR) per April 1, 2017. He succeeds Denise Haylor, who has decided to leave Philips for family reasons. A separate announcement will be made with regard to Ronald de Jong’s succession as Chief Market Leader.

"In 2016, Philips made significant progress with its strategic transformation to a focused leader in health technology and we have good momentum," said Frans van Houten, Chief Executive Officer of Royal Philips. "Looking ahead, there is an opportunity for us to accelerate Philips' transition to a customer-centric solutions company, and further leverage advanced informatics, artificial intelligence and the Internet of Things into our health propositions and our way of working. I am convinced that with the new responsibilities of Jeroen, Carla and Ronald within Philips' Executive Committee, we will be able to accelerate on our journey. We are thankful for Denise's significant contribution to shape the HR function at Philips over the last few years and we would like to wish her every success in her next endeavors. We would also like to wish Jean success for the future."

Jeroen Tas has over 30 years of experience as an entrepreneur and executive in the financial services, information technology and healthcare industries. In his previous role, he was successful in turning around and growing our Philips' healthcare IT business and establishing HealthSuite as the new open industry standard for the 'Internet of Things' in healthcare.

Since 2015, Carla Kriwet has successfully driven profitable growth and innovation in the Business Group Patient Care & Monitoring Solutions. Among other important achievements, she seeded new growth initiatives based on connected wearable biosensors and established new business partnerships.

As Philips' Chief Market Leader, Ronald de Jong has led the transformation of Philips' markets organization in the last five years towards a locally relevant, customer-centric solutions approach, significantly contributing to Philips’ solid growth and profitability improvement in 2016. In doing so, his team has built new capabilities, driven change management, and attracted new talent.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...

Philips and Merck Partner to Advance Per…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a multi-year partnership with Merck, a leading science and technology company, to develop clinical-grade digital solutions for...